As we observed very little apoptosis associated with the various treatments employed to inhibit PI3K or AKT, we subsequently investigated the cellular response to the inhibition of this signalling pathway as well as to exposure to gemcitabine, a standard chemotherapy for pancreatic cancer. The gene discussed is AKT1; the disease is familial pancreatic carcinoma.